Cambrex to announce third quarter 2017 financial results on November 7, 2017

East Rutherford, NJ – October 31, 2017 – Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that third quarter 2017 financial results will be released on Tuesday, November 7, 2017 before the market opens.

The Company will host a conference call to discuss the financial results.

Third Quarter 2017 Earnings Conference Call

When: Tuesday, November 7, 2017 at 8:30 a.m. Eastern Time

Dial-in:

  • 1-866-548-4713 for U.S.
  • 1-323-794-2093 for International
  • Passcode:  1511082

Dial-in Replay:

  • 1-888-203-1112 for U.S.
  • 1-719-457-0820 for International
  • Passcode:  1511082
  • Available through Tuesday, November 14, 2017

Webcast: www.cambrex.com

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.  For more information, please visit www.cambrex.com.

Contact: Stephanie LaFiura

Investor Relations Associate

Tel: 201-804-3037

Email: stephanie.lafiura@cambrex.com

Cambrex Icon
Posted by Cambrex
Tags